Shorla Oncology Drug Patent Portfolio
Shorla Oncology owns 1 orange book drug protected by 1 US patent Given below is the list of Shorla Oncology's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11957681 | Liquid dosage forms of Imatinib | 27 Apr, 2040 | Active |
Shorla Oncology's Family Patents
Shorla Oncology Drug List
Given below is the complete list of Shorla Oncology's drugs and the patents protecting them.
1. Imkeldi
Imkeldi is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11957681 | Liquid dosage forms of Imatinib |
27 Apr, 2040
(15 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Imkeldi's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List